Location History:
- Limonest, FR (1976 - 1984)
- 69 760 Limonest, FR (1989)
Company Filing History:
Years Active: 1976-1989
Title: The Innovations of Jacques C Liautaud: Pioneering Prothrombin Complex Concentrates
Introduction
Jacques C Liautaud, based in Limonest, France, is a notable inventor recognized for his contributions to the field of medical science, particularly in the area of blood coagulation. With a total of six patents to his name, Liautaud's work focuses on the preparation of prothrombin complex concentrates which are essential for addressing blood coagulation difficulties.
Latest Patents
Among his latest patents, Jacques C Liautaud has developed innovative procedures for the preparation of intravenously administered prothrombin complex concentrates. Notably, he has patented a procedure that involves the adsorption and elution of prothrombinogenic compounds along with antithrombin III (AT III). This unique method requires the use of an adsorbing agent that can effectively bind both compounds in the presence of heparin during the elution stage. The resulting products aim to significantly improve treatment options for patients facing blood coagulation issues.
Career Highlights
Throughout his career, Jacques C Liautaud has made significant advancements in medical technology. He has been associated with reputable companies such as Institut Merieux and Société Anonyme Dite: L'Oréal, where he applied his expertise in developing breakthroughs in medical treatments.
Collaborations
Liautaud's journey in the field of innovation has been enriched by collaborations with esteemed professionals such as Jean F Pla and Robert A Plan. Their shared insights and teamwork have contributed to the successful development of his patented technologies.
Conclusion
Jacques C Liautaud embodies the spirit of innovation in medical science through his focused efforts on prothrombin complex concentrates. His patents not only represent his dedication to advancing medical treatments but also highlight the importance of collaboration and continuous research in overcoming challenges related to blood coagulation.